Abstract
IntroductionThe difficulty in re-growing and mineralizing new bone after severe fracture can result in loss of ambulation or limb. Here we describe the sequential roles of FGF-2 in inducing gene expression, cell growth and BMP-2 in gene expression and mineralization of bone.Materials and methodsThe regulation of gene expression was determined using real-time RTPCR (qRTPCR) and cell proliferation was measured by thymidine incorporation or fluorescent analysis of DNA content in MC3T3E1 osteoblast-like cells. Photomicroscopy was used to identify newly mineralized tissue and fluorescence was used to quantify mineralization.ResultsFibroblast growth factor-2 (FGF-2) had the greatest ability to induce proliferation after 24 hours of treatment when compared to transforming growth factor beta (TGFβ, insulin-like growth factor-1 (IGF-1), bone morphogenic protein (BMP-2), platelet derived growth factor (PDGF) or prostaglandin E2 (PGE2). We found that FGF-2 caused the most significant induction of expression of early growth response-1 (egr-1), fgf-2, cyclo-oxygenase-2 (cox-2), tgfβ and matrix metalloproteinase-3 (mmp-3) associated with proliferation and expression of angiogenic genes like vascular endothelial growth factor A (vegfA) and its receptor vegfr1. We found that FGF-2 significantly reduced gene expression associated with mineralization, e.g. collagen type-1 (col1a1), fibronectin (fn), osteocalcin (oc), IGF-1, noggin, bone morphogenic protein (bmp-2) and alkaline phosphatase (alp). In contrast, BMP-2 significantly stimulated expression of the mineralization associated genes but had little or no effect on gene expression associated with growth.ConclusionsThe ability of FGF-2 to re-program a mineralizing gene expression profile to one of proliferation suggests that FGF-2 plays a critical role of osteoblast growth in early fracture repair while BMP-2 is instrumental in stimulating mineralization.
Highlights
The difficulty in re-growing and mineralizing new bone after severe fracture can result in loss of ambulation or limb
Fibroblast growth factor-2 (FGF-2) had the greatest ability to induce proliferation after 24 hours of treatment when compared to transforming growth factor beta (TGFb, insulin-like growth factor-1 (IGF-1), bone morphogenic protein (BMP-2), platelet derived growth factor (PDGF) or prostaglandin E2 (PGE2)
We found that FGF-2 significantly reduced gene expression associated with mineralization, e.g. collagen type-1, fibronectin, osteocalcin, IGF-1, noggin, bone morphogenic protein and alkaline phosphatase
Summary
The difficulty in re-growing and mineralizing new bone after severe fracture can result in loss of ambulation or limb. The cellular events involved in bone formation include chemotaxis of osteoblast precursors, growth factor (GF) production, proliferation of committed osteoblast precursors, and the differentiation (mineralization) of osteoblasts. Bone formation requires expression of structural proteins such as collagen type I, osteocalcin, noggin and runx during mineralization [1]. To evaluate the physiological activity of FGF-2 and other growth factors, we studied their relative ability to influence proliferation of osteoblasts at a site of injury in a mineralized culture. When treated with differentiation media, these cultured osteoblasts have the ability to differentiate, including synthesis of alkaline phosphatase [8], type I collagen [9], osteocalcin [10,11] and mineralized matrix containing hydroxyapatite crystals [12]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.